iMOST CBC (Complete Blood Count)
Essenlix iMOST CBC accurately measures a patient’s red blood cell, white blood cell and platelet counts in less than 60 seconds, using a single drop of blood and simple steps.
Essenlix has submitted a 510(k) application, which is currently under review by the U.S. Food and Drug Administration (FDA).
CBC is a vital sign of a person’s health, and hence the most common lab test. It is a blood test that's frequently used for a variety of reasons: as a measure of general health, to diagnose a medical condition based on present symptoms, and to monitor medical conditions or medical treatments. CBC also detects a wide range of conditions including anemia, infection and leukemia, and is used in oncology monitoring. A mobile test that provides CBC results in approximately 60 seconds will have significant impact on health monitoring, diagnosis and treatment.
iMOST CBC uses a simple finger-held device with a mobile phone and can be operated by a layman. Yet iMOST CBC achieves clinic-grade accuracy when under imperfect conditions (sample, instruments, operation, etc.). iMOST CBC uses game-changing new technologies that are based on unique “outside-of-the box” thinking realized using nanotechnology, advanced imaging, artificial intelligence/machine learning and advanced biology. The new technologies include SuperSmear™, IAA™, and Intelligent Assay™.